Data updated: Mar 10, 2026
CLOBETASOL PROPIONATE
CLOBETASOL PROPIONATE
Approved 1994-02-16
70
Indications
--
Phase 3 Trials
32
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1994-02-16
- Routes
- TOPICAL
- Dosage Forms
- AEROSOL, FOAM, LOTION, OINTMENT, SOLUTION, SHAMPOO, SPRAY, CREAM, GEL
Companies
TARO EPIC PHARMA LLC ALEMBIC SUN PHARMA CANADA Teva GLENMARK SPECLT AMNEAL FOUGERA PHARMS PADAGIS ISRAEL ZYDUS PHARMS Lupin Aurobindo Pharma ENCUBE CHARTWELL RX QUAGEN RISING SAPTALIS PHARMS TORRENT PRINSTON INC COSETTE WOCKHARDT BIO AG NOVEL LABS INC XIROMED GLENMARK PHARMS LTD PADAGIS US PAI HOLDINGS PHARM MACLEODS PHARMS LTD Apotex Hikma SCIEGEN PHARMS BEACH PRODS FOUGERA PHARMS INC ZYDUS LIFESCIENCES NOVAST LABS
Active Ingredient: CLOBETASOL PROPIONATE
Website: ↗
CLOBETASOL PROPIONATE Approval History
Loading approval history...
What CLOBETASOL PROPIONATE Treats
70 FDA approvalsOriginally approved for its first indication in 1994 . Covers 70 distinct patient populations.
- Other (70)
Other
(70 approvals)- • Approved indication (Feb 1994)
- • Approved indication (Aug 1994)
- • Approved indication (Dec 1995)
- • Approved indication (Feb 1996)
- • Approved indication (Jul 1996)
- • Approved indication (Jul 1996)
- • Approved indication (Sep 1996)
- • Approved indication (Oct 1997)
- • Approved indication (Aug 1998)Letter
- • Approved indication (Nov 1998)Letter
- • Approved indication (Nov 1998)Letter
- • Approved indication (Feb 1999)Letter
- • Approved indication (May 1999)Letter
- • Approved indication (Feb 2000)Letter
- • Approved indication (Dec 2000)Letter
- • Approved indication (Feb 2001)Letter
- • Approved indication (Aug 2005)
- • Approved indication (Mar 2008)Letter
- • Approved indication (Dec 2008)Letter
- • Approved indication (Jun 2011)Letter
- • Approved indication (Jun 2011)
- • Approved indication (Jul 2012)
- • Approved indication (Aug 2012)
- • Approved indication (Aug 2012)Letter
- • Approved indication (Nov 2015)
- • Approved indication (Nov 2016)
- • Approved indication (Feb 2017)
- • Approved indication (Mar 2017)
- • Approved indication (Mar 2017)
- • Approved indication (Apr 2017)
- • Approved indication (Jul 2017)
- • Approved indication (Sep 2017)
- • Approved indication (Oct 2017)
- • Approved indication (Oct 2017)
- • Approved indication (Jan 2018)
- • Approved indication (Mar 2018)
- • Approved indication (Apr 2018)
- • Approved indication (Apr 2018)
- • Approved indication (May 2018)
- • Approved indication (May 2018)
- • Approved indication (Jun 2018)
- • Approved indication (Aug 2018)
- • Approved indication (Oct 2018)
- • Approved indication (Oct 2018)
- • Approved indication (Oct 2018)
- • Approved indication (Dec 2018)
- • Approved indication (Jan 2019)
- • Approved indication (Jan 2019)
- • Approved indication (Feb 2019)
- • Approved indication (Mar 2019)
- • Approved indication (Sep 2019)
- • Approved indication (Sep 2019)
- • Approved indication (Oct 2019)
- • Approved indication (Oct 2019)
- • Approved indication (Oct 2019)
- • Approved indication (Nov 2019)
- • Approved indication (Dec 2019)
- • Approved indication (Jan 2020)
- • Approved indication (May 2020)
- • Approved indication (Aug 2020)
- • Approved indication (Feb 2021)
- • Approved indication (Mar 2021)
- • Approved indication (Mar 2021)
- • Approved indication (Jun 2021)
- • Approved indication (Feb 2022)
- • Approved indication (Apr 2022)
- • Approved indication (Dec 2023)
- • Approved indication (Mar 2024)
- • Approved indication (Dec 2024)
- • Approved indication (Nov 2025) New
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CLOBETASOL PROPIONATE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.